TY - STD TI - Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science (80- ). 2004/03/16 ed. 2004;304(5670):554. ID - ref1 ER - TY - STD TI - Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol. 2009/06/24 ed. 2009;19(2):231–4. ID - ref2 ER - TY - STD TI - Kelleher 3rd RJ, Bear MF. The autistic neuron: troubled translation? Cell. 2008/11/06 ed. 2008;135(3):401–6. ID - ref3 ER - TY - STD TI - Chen J, Alberts I, Li X. Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders. Int J Dev Neurosci. 2014/03/26 ed. 2014;35:35–41. ID - ref4 ER - TY - STD TI - Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, et al. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci. 2010/08/13 ed. 2010;30(32):10624–38. ID - ref5 ER - TY - STD TI - Castro J, Mellios N, Sur M. Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome. Curr Opin Neurol. 2013/03/02 ed. 2013;26(2):154–9. ID - ref6 ER - TY - STD TI - Kalkman HO. The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther. 2006/01/26 ed. 2006;110(1):117–34. ID - ref7 ER - TY - STD TI - Law AJ, Wang Y, Sei Y, O’Donnell P, Piantadosi P, Papaleo F, et al. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110delta inhibition as a potential therapeutic strategy. Proc Natl Acad Sci U S A. 2012/06/13 ed. 2012;109(30):12165–70. ID - ref8 ER - TY - STD TI - Zheng W, Wang H, Zeng Z, Lin J, Little PJ, Srivastava LK, et al. The possible role of the Akt signaling pathway in schizophrenia. Brain Res. 2012/07/10 ed. 2012;1470:145–58. ID - ref9 ER - TY - STD TI - Waite K, Eickholt BJ. The neurodevelopmental implications of PI3K signaling. Curr Top Microbiol Immunol. 2010/06/29 ed. 2010;346:245–65. ID - ref10 ER - TY - STD TI - Junttila TT, Sundvall M, Maatta JA, Elenius K. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med. 2001/05/10 ed. 2000;10(7):304–10. ID - ref11 ER - TY - STD TI - Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet. 2006/01/13 ed. 2006;141B(2):142–8. ID - ref12 ER - TY - STD TI - Seshadri S, Kamiya A, Yokota Y, Prikulis I, Kano S, Hayashi-Takagi A, et al. Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci U S A. 2010/03/10 ed. 2010;107(12):5622–7. ID - ref13 ER - TY - STD TI - Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, et al. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci U S A. 2010/08/18 ed. 2010;107(35):15619–24. ID - ref14 ER - TY - STD TI - Paterson C, Law AJ. Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood. PLoS One. 2014/08/06 ed. 2014;9(8):e104172. ID - ref15 ER - TY - STD TI - Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004/01/28 ed. 2004;36(2):131–7. ID - ref16 ER - TY - STD TI - Zhao Z, Ksiezak-Reding H, Riggio S, Haroutunian V, Pasinetti GM. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res. 2006/04/04 ed. 2006;84(1):1–14. ID - ref17 ER - TY - STD TI - Emamian ES. AKT/GSK3 signaling pathway and schizophrenia. Front Mol Neurosci. 2012/03/22 ed. 2012;5:33. ID - ref18 ER - TY - STD TI - Martin-Pena A, Acebes A, Rodriguez JR, Sorribes A, de Polavieja GG, Fernandez-Funez P, et al. Age-independent synaptogenesis by phosphoinositide 3 kinase. J Neurosci. 2006/10/06 ed. 2006;26(40):10199–208. ID - ref19 ER - TY - JOUR AU - Cuesto, G. AU - Enriquez-Barreto, L. AU - Carames, C. AU - Cantarero, M. AU - Gasull, X. AU - Sandi, C. PY - 2011 DA - 2011// TI - Phosphoinositide-3-kinase activation controls synaptogenesis and spinogenesis in hippocampal neurons JO - J Neurosci VL - 31 UR - https://doi.org/10.1523/JNEUROSCI.4477-10.2011 DO - 10.1523/JNEUROSCI.4477-10.2011 ID - Cuesto2011 ER - TY - JOUR AU - Enriquez-Barreto, L. AU - Cuesto, G. AU - Dominguez-Iturza, N. AU - Gavilan, E. AU - Ruano, D. AU - Sandi, C. PY - 2014 DA - 2014// TI - Learning improvement after PI3K activation correlates with de novo formation of functional small spines JO - Front Mol Neurosci. VL - 6 UR - https://doi.org/10.3389/fnmol.2013.00054 DO - 10.3389/fnmol.2013.00054 ID - Enriquez-Barreto2014 ER - TY - JOUR AU - Cuesto, G. AU - Jordán-Álvarez, S. AU - Enriquez-Barreto, L. AU - Ferrús, A. AU - Morales, M. AU - Acebes, Á. PY - 2015 DA - 2015// TI - GSK3β inhibition promotes synaptogenesis in Drosophila and mammalian neurons JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0118475 DO - 10.1371/journal.pone.0118475 ID - Cuesto2015 ER - TY - STD TI - Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature. 1985/05/16 ed. 1985;315(6016):239–42. ID - ref23 ER - TY - STD TI - Whitman M, Downes CP, Keeler M, Keller T, Cantley L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature. 1988/04/14 ed. 1988;332(6165):644–6. ID - ref24 ER - TY - STD TI - Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010/04/10 ed. 2010;11(5):329–41. ID - ref25 ER - TY - STD TI - Gross C, Bassell GJ. Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders. Front Mol Neurosci. 2014/03/05 ed. 2014;7:12. ID - ref26 ER - TY - STD TI - Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014/06/06 ed. 2014;46(6):372–83. ID - ref27 ER - TY - STD TI - Zhao L, Vogt PK. Class I PI3K in oncogenic cellular transformation. Oncogene. 2008/09/17 ed. 2008;27(41):5486–96. ID - ref28 ER - TY - STD TI - Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol. 2012/02/24 ed. 2012;13(3):195–203. ID - ref29 ER - TY - STD TI - Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005/11/16 ed. 2005;8(12):1727–34. ID - ref30 ER - TY - STD TI - Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998/06/05 ed. 1998;273(22):13375–8. ID - ref31 ER - TY - STD TI - Ali IU, Schriml LM, Dean M. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst. 1999/11/24 ed. 1999;91(22):1922–32. ID - ref32 ER - TY - STD TI - Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005/04/05 ed. 2005;42(4):318–21. ID - ref33 ER - TY - STD TI - Caronna EB, Milunsky JM, Tager-Flusberg H. Autism spectrum disorders: clinical and research frontiers. Arch Dis Child. 2008/02/29 ed. 2008;93(6):518–23. ID - ref34 ER - TY - STD TI - CDC | Data and Statistics | Autism Spectrum Disorder (ASD) | NCBDDD [Internet]. [cited 2015 Sep 18]. Available from: http://www.cdc.gov/ncbddd/autism/data.html UR - http://www.cdc.gov/ncbddd/autism/data.html ID - ref35 ER - TY - STD TI - Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA. 2003/07/17 ed. 2003;290(3):337–44. ID - ref36 ER - TY - STD TI - Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 2008/02/09 ed. 2008;31(3):137–45. ID - ref37 ER - TY - STD TI - Heaton P, Wallace GL. Annotation: the savant syndrome. J Child Psychol Psychiatry. 2004/07/01 ed. 2004;45(5):899–911. ID - ref38 ER - TY - JOUR AU - Südhof, T. C. PY - 2008 DA - 2008// TI - Neuroligins and neurexins link synaptic function to cognitive disease JO - Nature VL - 455 UR - https://doi.org/10.1038/nature07456 DO - 10.1038/nature07456 ID - Südhof2008 ER - TY - STD TI - Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 1997/10/23 ed. 1997;387(2):167–78. ID - ref40 ER - TY - STD TI - Delorme R, Ey E, Toro R, Leboyer M, Gillberg C, Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat Med. 2013/06/08 ed. 2013;19(6):685–94. ID - ref41 ER - TY - STD TI - Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet. 2003/04/02 ed. 2003;34(1):27–9. ID - ref42 ER - TY - JOUR AU - Nelson, S. B. AU - Valakh, V. PY - 2015 DA - 2015// TI - Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders JO - Neuron VL - 87 UR - https://doi.org/10.1016/j.neuron.2015.07.033 DO - 10.1016/j.neuron.2015.07.033 ID - Nelson2015 ER - TY - STD TI - Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2006/12/19 ed. 2007;39(1):25–7. ID - ref44 ER - TY - STD TI - Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy J V, Bomar JM, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet. 2008/01/09 ed. 2008;82(1):150–9. ID - ref45 ER - TY - STD TI - Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet. 2008/01/09 ed. 2008;82(1):199–207. ID - ref46 ER - TY - STD TI - Canitano R. Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry. 2006/08/26 ed. 2007;16(1):61–6. ID - ref47 ER - TY - STD TI - Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1977/09/01 ed. 1977;18(4):297–321. ID - ref48 ER - TY - STD TI - Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. JAMA. 2014/05/06 ed. 2014;311(17):1770–7. ID - ref49 ER - TY - STD TI - Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006/07/01 ed. 2006;29(7):349–58. ID - ref50 ER - TY - STD TI - Riikonen R, Makkonen I, Vanhala R, Turpeinen U, Kuikka J, Kokki H. Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. Dev Med Child Neurol. 2006/08/15 ed. 2006;48(9):751–5. ID - ref51 ER - TY - STD TI - Sheikh AM, Malik M, Wen G, Chauhan A, Chauhan V, Gong CX, et al. BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects. J Neurosci Res. 2010/07/22 ed. 2010;88(12):2641–7. ID - ref52 ER - TY - JOUR AU - Jansen, L. A. AU - Mirzaa, G. M. AU - Ishak, G. E. AU - O’Roak, B. J. AU - Hiatt, J. B. AU - Roden, W. H. PY - 2015 DA - 2015// TI - PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia JO - Brain VL - 138 UR - https://doi.org/10.1093/brain/awv045 DO - 10.1093/brain/awv045 ID - Jansen2015 ER - TY - STD TI - Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet. 2012/06/26 ed. 2012;44(8):941–5. ID - ref54 ER - TY - STD TI - Riviere JB, Mirzaa GM, O’Roak BJ, Beddaoui M, Alcantara D, Conway RL, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012/06/26 ed. 2012;44(8):934–40. ID - ref55 ER - TY - JOUR AU - Poduri, A. AU - Evrony, G. D. AU - Cai, X. AU - Elhosary, P. C. AU - Beroukhim, R. AU - Lehtinen, M. K. PY - 2012 DA - 2012// TI - Somatic activation of AKT3 causes hemispheric developmental brain malformations JO - Neuron VL - 74 UR - https://doi.org/10.1016/j.neuron.2012.03.010 DO - 10.1016/j.neuron.2012.03.010 ID - Poduri2012 ER - TY - JOUR AU - Zurashvili, T. AU - Cordón-Barris, L. AU - Ruiz-Babot, G. AU - Zhou, X. AU - Lizcano, J. M. AU - Gómez, N. PY - 2013 DA - 2013// TI - Interaction of PDK1 with phosphoinositides is essential for neuronal differentiation but dispensable for neuronal survival JO - Mol Cell Biol VL - 33 UR - https://doi.org/10.1128/MCB.01052-12 DO - 10.1128/MCB.01052-12 ID - Zurashvili2013 ER - TY - STD TI - Varga EA, Pastore M, Prior T, Herman GE, McBride KL. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med. 2009/03/07 ed. 2009;11(2):111–7. ID - ref58 ER - TY - STD TI - McBride KL, Varga EA, Pastore MT, Prior TW, Manickam K, Atkin JF, et al. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 2010/06/10 ed. 2010;3(3):137–41. ID - ref59 ER - TY - STD TI - Stiles B, Groszer M, Wang S, Jiao J, Wu H. PTENless means more. Dev Biol. 2004/08/26 ed. 2004;273(2):175–84. ID - ref60 ER - TY - STD TI - Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M. Control of dendritic arborization by the phosphoinositide-3’-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci. 2005/12/13 ed. 2005;25(49):11300–12. ID - ref61 ER - TY - STD TI - Acebes A, Devaud JM, Arnes M, Ferrus A. Central adaptation to odorants depends on PI3K levels in local interneurons of the antennal lobe. J Neurosci. 2012/01/13 ed. 2012;32(2):417–22. ID - ref62 ER - TY - STD TI - Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, et al. Pten regulates neuronal arborization and social interaction in mice. Neuron. 2006/05/06 ed. 2006;50(3):377–88. ID - ref63 ER - TY - STD TI - Lugo JN, Smith GD, Arbuckle EP, White J, Holley AJ, Floruta CM, et al. Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins. Front Mol Neurosci. 2014/05/06 ed. 2014;7:27. ID - ref64 ER - TY - STD TI - Burket JA, Benson AD, Tang AH, Deutsch SI. Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders. Brain Res Bull. 2013/12/04 ed. 2014;100:70–5. ID - ref65 ER - TY - STD TI - Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet. 2005/10/26 ed. 2005;14 Spec No:R251–8. ID - ref66 ER - TY - JOUR AU - O’Callaghan, F. J. AU - Shiell, A. W. AU - Osborne, J. P. AU - Martyn, C. N. PY - 1998 DA - 1998// TI - Prevalence of tuberous sclerosis estimated by capture-recapture analysis JO - Lancet (London, England) VL - 351 UR - https://doi.org/10.1016/S0140-6736(05)78872-3 DO - 10.1016/S0140-6736(05)78872-3 ID - O’Callaghan1998 ER - TY - STD TI - Spence SJ, Sharifi P, Wiznitzer M. Autism spectrum disorder: screening, diagnosis, and medical evaluation. Semin Pediatr Neurol. 2004/12/04 ed. 2004;11(3):186–95. ID - ref68 ER - TY - STD TI - Ridler K, Suckling J, Higgins NJ, de Vries PJ, Stephenson CM, Bolton PF, et al. Neuroanatomical correlates of memory deficits in tuberous sclerosis complex. Cereb Cortex. 2006/04/11 ed. 2007;17(2):261–71. ID - ref69 ER - TY - STD TI - Ehninger D, Silva AJ. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders. Trends Mol Med. 2010/12/01 ed. 2011;17(2):78–87. ID - ref70 ER - TY - JOUR AU - Acebes, A. AU - Ferrús, A. PY - 2001 DA - 2001// TI - Increasing the number of synapses modifies olfactory perception in Drosophila JO - J Neurosci VL - 21 ID - Acebes2001 ER - TY - STD TI - Ehninger D. From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches. Neuropharmacology. 2012/05/26 ed. 2013;68:97–105. ID - ref72 ER - TY - JOUR AU - Aksamitiene, E. AU - Kiyatkin, A. AU - Kholodenko, B. N. PY - 2012 DA - 2012// TI - Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance JO - Biochem Soc Trans VL - 40 UR - https://doi.org/10.1042/BST20110609 DO - 10.1042/BST20110609 ID - Aksamitiene2012 ER - TY - JOUR AU - Atwal, J. K. AU - Massie, B. AU - Miller, F. D. AU - Kaplan, D. R. PY - 2000 DA - 2000// TI - The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase JO - Neuron VL - 27 UR - https://doi.org/10.1016/S0896-6273(00)00035-0 DO - 10.1016/S0896-6273(00)00035-0 ID - Atwal2000 ER - TY - JOUR AU - Kumar, V. AU - Zhang, M. -. X. AU - Swank, M. W. AU - Kunz, J. AU - Wu, G. -. Y. PY - 2005 DA - 2005// TI - Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways JO - J Neurosci VL - 25 UR - https://doi.org/10.1523/JNEUROSCI.2284-05.2005 DO - 10.1523/JNEUROSCI.2284-05.2005 ID - Kumar2005 ER - TY - JOUR AU - Medina, D. L. AU - Sciarretta, C. AU - Calella, A. M. AU - Bohlen Und Halbach, O. AU - Unsicker, K. AU - Minichiello, L. PY - 2004 DA - 2004// TI - TrkB regulates neocortex formation through the Shc/PLCgamma-mediated control of neuronal migration JO - EMBO J VL - 23 UR - https://doi.org/10.1038/sj.emboj.7600399 DO - 10.1038/sj.emboj.7600399 ID - Medina2004 ER - TY - STD TI - Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013/07/24 ed. 2013;14:355–69. ID - ref77 ER - TY - JOUR AU - Rasmussen, S. A. AU - Friedman, J. M. PY - 2000 DA - 2000// TI - NF1 gene and neurofibromatosis 1 JO - Am J Epidemiol VL - 151 UR - https://doi.org/10.1093/oxfordjournals.aje.a010118 DO - 10.1093/oxfordjournals.aje.a010118 ID - Rasmussen2000 ER - TY - STD TI - Dasgupta B, Yi Y, Chen DY, Weber JD, Gutmann DH. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res. 2005/04/05 ed. 2005;65(7):2755–60. ID - ref79 ER - TY - STD TI - Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 1992/04/23 ed. 1992;356(6371):713–5. ID - ref80 ER - TY - JOUR AU - Kodaki, T. AU - Woscholski, R. AU - Hallberg, B. AU - Rodriguez-Viciana, P. AU - Downward, J. AU - Parker, P. J. PY - 1994 DA - 1994// TI - The activation of phosphatidylinositol 3-kinase by Ras JO - Curr Biol VL - 4 UR - https://doi.org/10.1016/S0960-9822(00)00177-9 DO - 10.1016/S0960-9822(00)00177-9 ID - Kodaki1994 ER - TY - JOUR AU - Rodriguez-Viciana, P. AU - Warne, P. H. AU - Dhand, R. AU - Vanhaesebroeck, B. AU - Gout, I. AU - Fry, M. J. PY - 1994 DA - 1994// TI - Phosphatidylinositol-3-OH kinase direct target of Ras JO - Nature VL - 370 UR - https://doi.org/10.1038/370527a0 DO - 10.1038/370527a0 ID - Rodriguez-Viciana1994 ER - TY - STD TI - Johnson NS, Saal HM, Lovell AM, Schorry EK. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr. 1999/06/04 ed. 1999;134(6):767–72. ID - ref83 ER - TY - STD TI - Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics. 2013/11/06 ed. 2013;132(6):e1642–8. ID - ref84 ER - TY - STD TI - Ostendorf AP, Gutmann DH, Weisenberg JL. Epilepsy in individuals with neurofibromatosis type 1. Epilepsia. 2013/09/17 ed. 2013;54(10):1810–4. ID - ref85 ER - TY - STD TI - Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol. 2005/11/08 ed. 2005;15(21):1961–7. ID - ref86 ER - TY - STD TI - Bagni C, Greenough WT. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci. 2005/04/30 ed. 2005;6(5):376–87. ID - ref87 ER - TY - JOUR AU - Coffee, B. AU - Keith, K. AU - Albizua, I. AU - Malone, T. AU - Mowrey, J. AU - Sherman, S. L. PY - 2009 DA - 2009// TI - Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA JO - Am J Hum Genet VL - 85 UR - https://doi.org/10.1016/j.ajhg.2009.09.007 DO - 10.1016/j.ajhg.2009.09.007 ID - Coffee2009 ER - TY - STD TI - Brown V, Jin P, Ceman S, Darnell JC, O’Donnell WT, Tenenbaum SA, et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 2001/11/24 ed. 2001;107(4):477–87. ID - ref89 ER - TY - JOUR AU - Tassone, F. AU - Hagerman, P. J. AU - Hagerman, R. J. PY - 2014 DA - 2014// TI - Fragile x premutation JO - J Neurodev Disord VL - 6 UR - https://doi.org/10.1186/1866-1955-6-22 DO - 10.1186/1866-1955-6-22 ID - Tassone2014 ER - TY - STD TI - Osterweil EK, Krueger DD, Reinhold K, Bear MF. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci. 2010/11/19 ed. 2010;30(46):15616–27. ID - ref91 ER - TY - STD TI - Qin M, Schmidt KC, Zametkin AJ, Bishu S, Horowitz LM, Burlin T V, et al. Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice. J Cereb Blood Flow Metab. 2013/01/10 ed. 2013;33(4):499–507. ID - ref92 ER - TY - STD TI - Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med. 1995/02/01 ed. 1995;1(2):159–67. ID - ref93 ER - TY - STD TI - Schapiro MB, Murphy DG, Hagerman RJ, Azari NP, Alexander GE, Miezejeski CM, et al. Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolism. Am J Med Genet. 1995/12/18 ed. 1995;60(6):480–93. ID - ref94 ER - TY - STD TI - Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A. 2002/05/29 ed. 2002;99(11):7746–50. ID - ref95 ER - TY - STD TI - Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004/06/29 ed. 2004;27(7):370–7. ID - ref96 ER - TY - STD TI - Krueger DD, Bear MF. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med. 2010/11/26 ed. 2010;62:411–29. ID - ref97 ER - TY - STD TI - Pop AS, Levenga J, de Esch CE, Buijsen RA, Nieuwenhuizen IM, Li T, et al. Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant. Psychopharmacol. 2012/12/21 ed. 2014;231(6):1227–35. ID - ref98 ER - TY - STD TI - Yan QJ, Rammal M, Tranfaglia M, Bauchwitz RP. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology. 2005/08/02 ed. 2005;49(7):1053–66. ID - ref99 ER - TY - STD TI - Zhang J, Hou L, Klann E, Nelson DL. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. J Neurophysiol. 2009/02/27 ed. 2009;101(5):2572–80. ID - ref100 ER - TY - STD TI - Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010/01/15 ed. 2010;30(2):694–702. ID - ref101 ER - TY - STD TI - Niere F, Wilkerson JR, Huber KM. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. J Neurosci. 2012/04/28 ed. 2012;32(17):5924–36. ID - ref102 ER - TY - STD TI - Hoeffer CA, Sanchez E, Hagerman RJ, Mu Y, Nguyen D V, Wong H, et al. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav. 2012/01/25 ed. 2012;11(3):332–41. ID - ref103 ER - TY - STD TI - Busquets-Garcia A, Gomis-Gonzalez M, Guegan T, Agustin-Pavon C, Pastor A, Mato S, et al. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med. 2013/04/02 ed. 2013;19(5):603–7. ID - ref104 ER - TY - STD TI - Gross C, Bassell GJ. Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110beta-selective inhibitor. Mol Med. 2011/12/31 ed. 2012;18:336–45. ID - ref105 ER - TY - JOUR AU - Kozinetz, C. A. AU - Skender, M. L. AU - MacNaughton, N. AU - Almes, M. J. AU - Schultz, R. J. AU - Percy, A. K. PY - 1993 DA - 1993// TI - Epidemiology of Rett syndrome: a population-based registry JO - Pediatrics VL - 91 ID - Kozinetz1993 ER - TY - STD TI - Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999/10/03 ed. 1999;23(2):185–8. ID - ref107 ER - TY - STD TI - Shahbazian MD, Sun Y, Zoghbi HY. Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet. 2002/09/05 ed. 2002;111(2):164–8. ID - ref108 ER - TY - STD TI - Yasui DH, Xu H, Dunaway KW, Lasalle JM, Jin LW, Maezawa I. MeCP2 modulates gene expression pathways in astrocytes. Mol Autism. 2013/01/29 ed. 2013;4(1):3. ID - ref109 ER - TY - STD TI - Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet. 2001/03/10 ed. 2001;27(3):327–31. ID - ref110 ER - TY - STD TI - Kishi N, Macklis JD. Dissecting MECP2 function in the central nervous system. J Child Neurol. 2005/10/18 ed. 2005;20(9):753–9. ID - ref111 ER - TY - STD TI - Tognini P, Putignano E, Coatti A, Pizzorusso T. Experience-dependent expression of miR-132 regulates ocular dominance plasticity. Nat Neurosci. 2011/09/06 ed. 2011;14(10):1237–9. ID - ref112 ER - TY - STD TI - Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002/08/27 ed. 2002;35(4):605–23. ID - ref113 ER - TY - STD TI - Im HI, Hollander JA, Bali P, Kenny PJ. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci. 2010/08/17 ed. 2010;13(9):1120–7. ID - ref114 ER - TY - STD TI - Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Loven J, et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell. 2013/10/08 ed. 2013;13(4):446–58. ID - ref115 ER - TY - STD TI - Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, Stefanelli G, et al. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet. 2011/01/08 ed. 2011;20(6):1182–96. ID - ref116 ER - TY - STD TI - Dastidar SG, Bardai FH, Ma C, Price V, Rawat V, Verma P, et al. Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1. J Neurosci. 2012/02/24 ed. 2012;32(8):2846–55. ID - ref117 ER - TY - STD TI - Kolbeck R, Bartke I, Eberle W, Barde YA. Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J Neurochem. 1999/04/27 ed. 1999;72(5):1930–8. ID - ref118 ER - TY - STD TI - Chang Q, Khare G, Dani V, Nelson S, Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron. 2006/02/01 ed. 2006;49(3):341–8. ID - ref119 ER - TY - STD TI - Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S, et al. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet. 2007/02/21 ed. 2007;16(6):640–50. ID - ref120 ER - TY - STD TI - Deogracias R, Yazdani M, Dekkers MP, Guy J, Ionescu MC, Vogt KE, et al. Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc Natl Acad Sci U S A. 2012/08/15 ed. 2012;109(35):14230–5. ID - ref121 ER - TY - STD TI - Schmid DA, Yang T, Ogier M, Adams I, Mirakhur Y, Wang Q, et al. A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. J Neurosci. 2012/02/04 ed. 2012;32(5):1803–10. ID - ref122 ER - TY - STD TI - Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A. 2009/02/12 ed. 2009;106(6):2029–34. ID - ref123 ER - TY - STD TI - Castro J, Garcia RI, Kwok S, Banerjee A, Petravicz J, Woodson J, et al. Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proc Natl Acad Sci U S A. 2014/06/25 ed. 2014;111(27):9941–6. ID - ref124 ER - TY - STD TI - Khwaja OS, Ho E, Barnes K V, O’Leary HM, Pereira LM, Finkelstein Y, et al. Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc Natl Acad Sci U S A. 2014/03/14 ed. 2014;111(12):4596–601. ID - ref125 ER - TY - STD TI - Maki P, Veijola J, Jones PB, Murray GK, Koponen H, Tienari P, et al. Predictors of schizophrenia--a review. Br Med Bull. 2005/06/11 ed. 2005;73–74:1–15. ID - ref126 ER - TY - STD TI - Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005/05/27 ed. 2005;2(5):e141. ID - ref127 ER - TY - STD TI - Karam CS, Ballon JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, et al. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends Pharmacol Sci. 2010/06/29 ed. 2010;31(8):381–90. ID - ref128 ER - TY - STD TI - Barch DM, Ceaser A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci. 2011/12/16 ed. 2012;16(1):27–34. ID - ref129 ER - TY - STD TI - Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry. 2012/04/11 ed. 2012;17(12):1228–38. ID - ref130 ER - TY - STD TI - Duan S, Gao R, Xing Q, Du J, Liu Z, Chen Q, et al. A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci Lett. 2005/04/09 ed. 2005;379(1):32–6. ID - ref131 ER - TY - STD TI - Stopkova P, Saito T, Papolos DF, Vevera J, Paclt I, Zukov I, et al. Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol Psychiatry. 2004/05/04 ed. 2004;55(10):981–8. ID - ref132 ER - TY - STD TI - Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M, et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet. 2005/05/14 ed. 2005;136B(1):12–25. ID - ref133 ER - TY - STD TI - Rico B. Finding a druggable target for schizophrenia. Proc Natl Acad Sci U S A. 2012/07/11 ed. 2012;109(30):11902–3. ID - ref134 ER - TY - STD TI - Caren H, Fransson S, Ejeskar K, Kogner P, Martinsson T. Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer. 2007/10/18 ed. 2007;97(10):1416–24. ID - ref135 ER - TY - STD TI - Fransson S, Martinsson T, Ejeskar K. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2. Genes Chromosom Cancer. 2006/10/18 ed. 2007;46(1):45–52. ID - ref136 ER - TY - STD TI - Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011/02/10 ed. 2011;63(1):182–217. ID - ref137 ER - TY - STD TI - Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, et al. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci U S A. 2005/02/18 ed. 2005;102(9):3513–8. ID - ref138 ER - TY - STD TI - Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry. 2004/11/04 ed. 2004;56(9):698–700. ID - ref139 ER - TY - STD TI - Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, et al. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry. 2007/09/11 ed. 2008;63(5):449–57. ID - ref140 ER - TY - STD TI - Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003/02/04 ed. 2003;160(2):284–9. ID - ref141 ER - TY - STD TI - Harris LW, Guest PC, Wayland MT, Umrania Y, Krishnamurthy D, Rahmoune H, et al. Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology. 2012/10/23 ed. 2013;38(6):752–66. ID - ref142 ER - TY - STD TI - Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P, et al. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci U S A. 2006/11/02 ed. 2006;103(45):16906–11. ID - ref143 ER - TY - STD TI - Peng L, Zhu D, Feng X, Dong H, Yue Q, Zhang J, et al. Paliperidone protects prefrontal cortical neurons from damages caused by MK-801 via Akt1/GSK3beta signaling pathway. Schizophr Res. 2013/04/16 ed. 2013;147(1):14–23. ID - ref144 ER - TY - STD TI - Selemon LD. A role for synaptic plasticity in the adolescent development of executive function. Transl Psychiatry. 2013/03/07 ed. 2013;3:e238. ID - ref145 ER - TY - STD TI - Lohmann C, Kessels HW. The developmental stages of synaptic plasticity. J Physiol. 2013/10/23 ed. 2014;592(Pt 1):13–31. ID - ref146 ER - TY - STD TI - Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 2010/07/09 ed. 2010;26(8):363–72. ID - ref147 ER - TY - STD TI - Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci. 2011/02/25 ed. 2011;14(3):285–93. ID - ref148 ER - TY - STD TI - Bock HH, Jossin Y, Liu P, Forster E, May P, Goffinet AM, et al. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem. 2003/07/29 ed. 2003;278(40):38772–9. ID - ref149 ER - TY - STD TI - Acebes A, Morales M. At a PI3K crossroads: lessons from flies and rodents. Rev Neurosci. 2012/06/22 ed. 2012;23(1):29–37. ID - ref150 ER - TY - STD TI - Arendt KL, Royo M, Fernandez-Monreal M, Knafo S, Petrok CN, Martens JR, et al. PIP3 controls synaptic function by maintaining AMPA receptor clustering at the postsynaptic membrane. Nat Neurosci. 2009/12/17 ed. 2010;13(1):36–44. ID - ref151 ER - TY - STD TI - Jurado S, Benoist M, Lario A, Knafo S, Petrok CN, Esteban JA. PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression. EMBO J. 2010/07/16 ed. 2010;29(16):2827–40. ID - ref152 ER - TY - STD TI - Sanna PP, Cammalleri M, Berton F, Simpson C, Lutjens R, Bloom FE, et al. Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. J Neurosci. 2002/04/30 ed. 2002;22(9):3359–65. ID - ref153 ER - TY - STD TI - Home - ClinicalTrials.gov [Internet]. [cited 2015 Sep 18]. Available from: https://www.clinicaltrials.gov/ UR - https://www.clinicaltrials.gov/ ID - ref154 ER - TY - JOUR AU - Yang, Q. AU - Modi, P. AU - Newcomb, T. AU - Quéva, C. AU - Gandhi, V. PY - 2015 DA - 2015// TI - Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2034 DO - 10.1158/1078-0432.CCR-14-2034 ID - Yang2015 ER - TY - JOUR AU - Hoeffer, C. A. AU - Klann, E. PY - 2010 DA - 2010// TI - mTOR signaling: at the crossroads of plasticity, memory and disease JO - Trends Neurosci VL - 33 UR - https://doi.org/10.1016/j.tins.2009.11.003 DO - 10.1016/j.tins.2009.11.003 ID - Hoeffer2010 ER -